Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review

Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by it to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counter products such as vitamins, nutritional supplements and calcium supplement, among others. Hanmi Pharma’s products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others. The company operates through its manufacturing facilities located in Hwaseong, Songpa, and Pyeongtaek, South Korea. Hanmi Pharma is headquartered in Seoul, South Korea.

Hanmi Pharmaceuticals Co Ltd Key Recent Developments

Jan 12,2017: Hanmi unveils new R&D strategy at JP Morgan Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 

Section 1 - About the Company 6
Hanmi Pharmaceuticals Co Ltd - Key Facts 6
Hanmi Pharmaceuticals Co Ltd - Key Employees 7
Hanmi Pharmaceuticals Co Ltd - Key Employee Biographies 8
Hanmi Pharmaceuticals Co Ltd - Major Products and Services 9
Hanmi Pharmaceuticals Co Ltd - History 10
Hanmi Pharmaceuticals Co Ltd - Company Statement 12
Hanmi Pharmaceuticals Co Ltd - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Hanmi Pharmaceuticals Co Ltd - Business Description 15
Business Segment: Medicines 15
Overview 15
Performance 15
Business Segment: Overseas Drugs 15
Overview 15
Performance 15
Business Segment: Raw Drugs 15
Overview 15
Performance 15
Geographical Segment: China 16
Performance 16
Geographical Segment: Others 16
Performance 16
Geographical Segment: Republic of Korea 16
Performance 16
Geographical Segment: The US 16
Performance 16
R&D Overview 16
Hanmi Pharmaceuticals Co Ltd - SWOT Analysis 17
SWOT Analysis - Overview 17
Hanmi Pharmaceuticals Co Ltd - Strengths 17
Hanmi Pharmaceuticals Co Ltd - Weaknesses 18
Hanmi Pharmaceuticals Co Ltd - Opportunities 19
Hanmi Pharmaceuticals Co Ltd - Threats 20
Hanmi Pharmaceuticals Co Ltd - Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Jan 12, 2017: Hanmi unveils new R&D strategy at JP Morgan Healthcare Conference 32
Section 6 – Appendix 33
Methodology 33
Ratio Definitions 33
Contact Us 37
Disclaimer 37


List Of Tables

Hanmi Pharmaceuticals Co Ltd, Key Facts 6
Hanmi Pharmaceuticals Co Ltd, Key Employees 7
Hanmi Pharmaceuticals Co Ltd, Key Employee Biographies 8
Hanmi Pharmaceuticals Co Ltd, Major Products and Services 9
Hanmi Pharmaceuticals Co Ltd, History 10
Hanmi Pharmaceuticals Co Ltd, Other Locations 13
Hanmi Pharmaceuticals Co Ltd, Subsidiaries 13
Hanmi Pharmaceuticals Co Ltd, Key Competitors 21
Hanmi Pharmaceuticals Co Ltd, Ratios based on current share price 22
Hanmi Pharmaceuticals Co Ltd, Annual Ratios 23
Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...1) 24
Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont...2) 25
Hanmi Pharmaceuticals Co Ltd, Interim Ratios 27
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary 31
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

 
 


List Of Figures

Hanmi Pharmaceuticals Co Ltd, Performance Chart (2013 - 2017) 26
Hanmi Pharmaceuticals Co Ltd, Ratio Charts 28
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


Hanmi Pharmaceuticals Co Ltd (128940) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The companys prescription drugs include osteoporosis,

USD 250 View Report

Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review

Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled

USD 125 View Report

North America Pharmaceuticals Cold Chain Logistics Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Pharmaceuticals Cold Chain Logistics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Global Pharmaceuticals Cold Chain Logistics Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of Pharmaceuticals Cold Chain Logistics is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available